Cytarabine

Basic Information

Item Value
DrugBank ID DB00987
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 92

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 small cell lung carcinoma KG + DL
2 primary pulmonary lymphoma KG + DL
3 well-differentiated fetal adenocarcinoma of the lung KG + DL
4 pulmonary blastoma KG + DL
5 upper aerodigestive tract neoplasm KG + DL
6 ganglioneuroblastoma (disease) KG + DL
7 vertebral anomalies and variable endocrine and T-cell dysfunction KG + DL
8 retroperitoneal neoplasm KG + DL
9 neuroblastoma KG + DL
10 chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation KG + DL
11 pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma KG + DL
12 chronic myelogenous leukemia, BCR-ABL1 positive KG + DL
13 adenosarcoma KG + DL
14 Ewing sarcoma KG + DL
15 uterine ligament adenosarcoma KG + DL
16 bladder exstrophy-epispadias-cloacal exstrophy complex KG + DL
17 bladder exstrophy (disease) KG + DL
18 malignant mixed epithelial and mesenchymal tumor of cervix uteri KG + DL
19 osteopathia striata with cranial sclerosis KG + DL
20 Keipert syndrome KG + DL
21 bulbar polio KG + DL
22 head and neck cancer KG + DL
23 5q35 microduplication syndrome KG + DL
24 ALK-positive large B-cell lymphoma KG + DL
25 blast phase chronic myelogenous leukemia, BCR-ABL1 positive KG + DL
26 obsolete Hodgkin’s granuloma KG + DL
27 unclassified myelodysplastic syndrome KG + DL
28 lung mixed small cell and squamous cell carcinoma KG + DL
29 refractory cytopenia of childhood KG + DL
30 partial deletion of the long arm of chromosome 5 KG + DL
31 2q33.1 microdeletion syndrome KG + DL
32 severe congenital hypochromic anemia with ringed sideroblasts KG + DL
33 aregenerative anemia KG + DL
34 skull base chordoma KG + DL
35 malignant neoplasm of acoustic nerve KG + DL
36 paranasal sinus cancer KG + DL
37 vestibule of mouth cancer KG + DL
38 retromolar area cancer KG + DL
39 neuralgic amyotrophy KG + DL
40 uveal cancer KG + DL
41 soft palate cancer KG + DL
42 Hodgkins lymphoma KG + DL
43 inner ear cancer KG + DL
44 lissencephaly spectrum disorders KG + DL
45 middle ear cancer KG + DL
46 external ear cancer KG + DL
47 amyotrophic neuralgia KG + DL
48 cornea cancer KG + DL
49 bladder transitional cell carcinoma KG + DL
50 chronic lymphocytic leukemia/small lymphocytic lymphoma KG + DL

(Showing top 50 of 92 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.